Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
Clinical trial NCT00616928 · COMPLETED
Trial details
- NCT number
- NCT00616928
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-23
- Primary completion
- 2008-10-15
- Enrollment
- 4561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.